Latest Shareholder Value News

Argo Investments Limited has announced the renewal of its on-market buy-back facility, allowing the company to repurchase up to 37 million ordinary shares throughout 2026 as part of its capital management strategy.

EPX Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at $0.25 each, matching a recent institutional placement price. The plan aims to raise up to $700,000 to support the company’s growth and working capital needs.

AnteoTech secures a significant order from the Serum Institute of India and expands its Life Sciences pipeline with new product developments and global partnerships, positioning for accelerated growth in 2026.

Vulcan Energy Resources has successfully closed its retail entitlement offer, raising €147 million and increasing HOCHTIEF's ownership to over 15%, eliminating the need for a conditional placement.

Omnia Metals Group has finalized its $1.58 million placement with the issue of 25 million shares and over 70 million options, setting the stage for renewed exploration and strategic growth.

The Supreme Court of New South Wales has approved the acquisition of Seven West Media by Southern Cross Media, marking a major consolidation in Australian media. SWM shares will be suspended from trading as shareholders prepare to receive Southern Cross shares in early January.

Ovanti Limited has raised $3 million through a discounted share placement to fund its expansion into the US buy now, pay later market and support ongoing litigation.

Corella Resources has completed the first tranche of a $1 million share placement, issuing over 142 million shares at $0.0035 each. The second tranche and attached options await shareholder approval in early 2026.

Pure Resources has completed a $1.7 million placement to fund its Garnet Hills Garnet and Graphite Project, with options to be issued pending shareholder approval.

Perseus Mining has expanded and refinanced its corporate debt facility to US$400 million, significantly enhancing its liquidity position to over US$1.2 billion. This move positions the gold miner strongly for future growth and shareholder returns.

American Tungsten & Antimony Ltd plans to unlock value by spinning out its Drummond Basin and NSW gold exploration assets into a new ASX-listed company, King Metals Limited, aiming to raise up to $6 million in an IPO.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.